Literature DB >> 20023267

Diagnostic usefulness of fluorescent cytogenetics in differentiating chromophobe renal cell carcinoma from renal oncocytoma: a validation study combining metaphase and interphase analyses.

Matteo Brunelli1, Brett Delahunt, Stefano Gobbo, Regina Tardanico, Albino Eccher, Samantha Bersani, Paolo Cossu-Rocca, Claudia Parolini, Piera Balzarini, Fabio Menestrina, Liang Cheng, John Nelson Eble, Guido Martignoni.   

Abstract

We investigated the usefulness of interphase fluorescence in situ hybridization (FISH) analysis to differentiate between 11 chromophobe renal carcinomas and 12 renal oncocytomas, showing different clinical outcomes, when compared with conventional metaphase cytogenetics by karyotyping. Karyotypically, 3 chromophobe renal cell carcinomas showed losses of chromosomes, 3 were polyploid, 1 was normal, and 4 failed to grow. Of 12 oncocytomas, 5 showed a normal numeric karyotype and 6 additional structural rearrangements. FISH on chromophobe renal cell carcinomas showed a high percentage of cases (10/11 [91%]) with multiple numeric losses among chromosomes 1, 2, 6, 10, and 17; this interphase pattern was observed irrespective of the 3 different metaphase karyotypes. Of 12 oncocytomas, 11 (92%) revealed a normal numeric chromosomal status showing at least 2 chromosomes without aneusomy by interphase FISH. The study demonstrates that indeed FISH performed on formalin-fixed, paraffin-embedded tissue can provide clinically useful information more reliably than karyotyping of most of these tumors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20023267     DOI: 10.1309/AJCPSATJTKBI6J4N

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

1.  Renal cell carcinoma: the search for a reliable biomarker.

Authors:  Nicholas J Farber; Christopher J Kim; Parth K Modi; Jane D Hon; Evita T Sadimin; Eric A Singer
Journal:  Transl Cancer Res       Date:  2017-06       Impact factor: 1.241

2.  Renal tumors: diagnostic and prognostic biomarkers.

Authors:  Puay Hoon Tan; Liang Cheng; Nathalie Rioux-Leclercq; Maria J Merino; George Netto; Victor E Reuter; Steven S Shen; David J Grignon; Rodolfo Montironi; Lars Egevad; John R Srigley; Brett Delahunt; Holger Moch
Journal:  Am J Surg Pathol       Date:  2013-10       Impact factor: 6.394

3.  Expression of histone methyltransferases as novel biomarkers for renal cell tumor diagnosis and prognostication.

Authors:  Ana Sílvia Pires-Luís; Márcia Vieira-Coimbra; Filipa Quintela Vieira; Pedro Costa-Pinheiro; Rui Silva-Santos; Paula C Dias; Luís Antunes; Francisco Lobo; Jorge Oliveira; Céline S Gonçalves; Bruno M Costa; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2015       Impact factor: 4.528

4.  Genetic alterations of HER genes in chromophobe renal cell carcinoma.

Authors:  Wen Hui Weng; Ying Tzu Chen; Kai Jie Yu; Ying Hsu Chang; Cheng Keng Chuang; See Tong Pang
Journal:  Oncol Lett       Date:  2016-02-08       Impact factor: 2.967

5.  Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.

Authors:  Maris Sperga; Petr Martinek; Tomas Vanecek; Petr Grossmann; Kevin Bauleth; Delia Perez-Montiel; Isabel Alvarado-Cabrero; Kristine Nevidovska; Vilnis Lietuvietis; Milan Hora; Michal Michal; Fredrik Petersson; Naoto Kuroda; Saul Suster; Jindrich Branzovsky; Ondrej Hes
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

6.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

7.  Combined Immunohistochemistry for the "Three 7" Markers (CK7, CD117, and Claudin-7) Is Useful in the Diagnosis of Chromophobe Renal Cell Carcinoma and for the Exclusion of Mimics: Diagnostic Experience from a Single Institution.

Authors:  Jun Zhou; Xiaoqun Yang; Luting Zhou; Peipei Zhang; Chaofu Wang
Journal:  Dis Markers       Date:  2019-10-13       Impact factor: 3.434

Review 8.  Genetic and Chromosomal Aberrations and Their Clinical Significance in Renal Neoplasms.

Authors:  Ning Yi Yap; Retnagowri Rajandram; Keng Lim Ng; Jayalakshmi Pailoor; Ahmad Fadzli; Glenda Carolyn Gobe
Journal:  Biomed Res Int       Date:  2015-09-13       Impact factor: 3.411

Review 9.  Magnetic Resonance Imaging as a Biomarker for Renal Cell Carcinoma.

Authors:  Yan Wu; Young Suk Kwon; Mina Labib; David J Foran; Eric A Singer
Journal:  Dis Markers       Date:  2015-11-01       Impact factor: 3.434

10.  Chromosome 17p13 deletion is associated with an aggressive tumor phenotype in clear cell renal cell carcinoma.

Authors:  Till Eichenauer; Navid Shadanpour; Martina Kluth; Cosima Göbel; Sören Weidemann; Christoph Fraune; Franziska Büscheck; Claudia Hube-Magg; Christina Möller-Koop; Roland Dahlem; Margit Fisch; Michael Rink; Silke Riechardt; Eike Burandt; Christian Bernreuther; Sarah Minner; Ronald Simon; Guido Sauter; Waldemar Wilczak; Till Clauditz
Journal:  World J Surg Oncol       Date:  2020-06-13       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.